We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Aptiv
APTV
$12B
| $418K | ﹤0.01% |
5,891
-7,239
| -55% | -$488K |
|
877
Aramark
ARMK
$15.2B
| $417K | ﹤0.01% |
15,228
-5,186
| -25% | -$137K |
|
|
S
878
DELISTED
Sprint Corporation
S
| $417K | ﹤0.01% |
63,091
-456
| -0.7% | -$2.7K |
|
|
NSR
879
DELISTED
Neustar Inc
NSR
| $417K | ﹤0.01% |
15,696
| – | – |
|
|
TGNA
880
DELISTED
TEGNA Inc
TGNA
| $412K | ﹤0.01% |
29,550
+2,947
| +11% | +$41.4K |
|
881
Universal Insurance Holdings
UVE
$1.23B
| $412K | ﹤0.01% |
16,380
| – | – |
|
882
BCE
BCE
$20B
| $411K | ﹤0.01% |
8,920
| – | – |
|
883
Annaly Capital Management
NLY
$17.1B
| $410K | ﹤0.01% |
9,788
+552
| +6% | +$23.9K |
|
884
Public Storage
PSA
$61.4B
| $410K | ﹤0.01% |
1,845
-45
| -2% | -$10.5K |
|
885
Pultegroup
PHM
$24.8B
| $408K | ﹤0.01% |
20,414
-2,760
| -12% | -$57.2K |
|
886
Performance Food Group
PFGC
$17.8B
| $407K | ﹤0.01% |
+16,417
| New | +$428K |
|
887
Kayne Anderson Energy Infrastructure Fund
KYN
$2.46B
| $403K | ﹤0.01% |
19,599
-2,100
| -10% | -$41K |
|
|
HSBC.PRA
888
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
| $402K | ﹤0.01% |
15,725
| – | – |
|
889
Invesco S&P 500 Low Volatility ETF
SPLV
$7.24B
| $395K | ﹤0.01% |
9,534
+117
| +1% | +$4.95K |
|
890
Vornado Realty Trust
VNO
$7.53B
| $394K | ﹤0.01% |
4,828
-1,098
| -19% | -$91K |
|
|
BCPC
891
Balchem Corp
BCPC
$5.25B
| $393K | ﹤0.01% |
5,088
-25
| -0.5% | -$1.66K |
|
892
Cheesecake Factory
CAKE
$4.26B
| $392K | ﹤0.01% |
7,840
-449
| -5% | -$22.9K |
|
893
Williams-Sonoma
WSM
$27.2B
| $392K | ﹤0.01% |
15,394
-890,326
| -98% | -$23.3M |
|
894
Lloyds Banking Group
LYG
$88.7B
| $390K | ﹤0.01% |
136,100
+682
| +0.5% | +$2.03K |
|
895
FirstEnergy
FE
$28.8B
| $386K | ﹤0.01% |
11,676
| – | – |
|
896
BWX Technologies
BWXT
$16.2B
| $384K | ﹤0.01% |
10,013
-722
| -7% | -$27.3K |
|
897
iShares S&P 500 Value ETF
IVE
$49.1B
| $384K | ﹤0.01% |
4,053
| – | – |
|
898
Plexus
PLXS
$6.59B
| $381K | ﹤0.01% |
8,150
+24
| +0.3% | +$1.1K |
|
|
SNBC
899
DELISTED
Sun Bancorp Inc
SNBC
| $376K | ﹤0.01% |
16,330
| – | – |
|
900
Fidelity National Information Services
FIS
$22.2B
| $375K | ﹤0.01% |
4,879
-715
| -13% | -$55.9K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.